We first published a valuation of Express Scripts in July 2015, and a lot has happened in the Pharmacy Benefits Management (PBM) industry since then. Insurance consolidation, drug company pricing, and intricate relationships between the players make this a difficult place to invest with a good bit of regulatory risk.